Results 151 to 160 of about 65,777 (239)
Temporal Dynamics of Viremia in Hemorrhagic Fever With Renal Syndrome Patients. [PDF]
Ma S +6 more
europepmc +1 more source
ABSTRACT Background and Aims An estimated 270 000 people in the UK live with hepatitis B infection, the leading global cause of liver cancer. In 2022, opt‐out hepatitis B testing was introduced in emergency departments (ED) in London. We conducted a 2‐year multicentre evaluation of this programme across seven sites.
Jennifer J. Plunkett +15 more
wiley +1 more source
Similar Changes in Proviral Landscapes Over 10 Years in 40 Individuals With Diverging HIV Reservoir Dynamics and Viral Load Kinetics. [PDF]
Tschumi J +12 more
europepmc +1 more source
ABSTRACT Background and Aim Hepatitis D virus (HDV) infection remains underdiagnosed, and real‐world data on screening and linkage to care are limited. We assessed the implementation of Opti‐Hep‐D, a publicly funded initiative for HDV management in the Spanish region of Catalonia.
Adriana Palom +20 more
wiley +1 more source
Trends in HIV Viral Suppression in the POP-UP Low-Barrier Care Program for People With HIV Experiencing Homelessness or Unstable Housing. [PDF]
Imbert E +23 more
europepmc +1 more source
Integrating Tissue Gene Expression Profiling With Histopathology in Pediatric Kidney Recipients
Tissue‐based molecular gene expression strongly correlates with histologic assessment and can provide diagnostic clarification in ambiguous pediatric kidney allograft biopsies. Integration of molecular diagnostics has the potential to improve diagnostic precision in pediatric kidney transplantation.
Clarkson Crane +4 more
wiley +1 more source
TTV Viremia and Immune Responses Following Vaccination Against Mpox and Dengue Viruses. [PDF]
Minosse C +17 more
europepmc +1 more source
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 10, Issue S1, June 2026.
wiley +1 more source
Abstract Background Screening blood donations for HEV RNA mitigates the risk of transfusion‐transmitted HEV infection (TT‐HEV), a recognised blood safety issue in Europe. This study reports the findings of government‐funded HEV RNA blood donation screening 2016–2022 and includes an estimate of residual risk. Method Donation samples were universally and
Niamh O'Flaherty +6 more
wiley +1 more source

